Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             42 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer Mertens, Laura S

25 2 p. 156-157
artikel
2 Accelerating progress on EU cancer control Charalambous, Andreas

25 2 p. 158-160
artikel
3 Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study Sathekge, Mike M

25 2 p. 175-183
artikel
4 2023 ASH annual meeting Cookson, Emma

25 2 p. 161
artikel
5 Cancer care and treatment during homelessness Asgary, Ramin

25 2 p. e84-e90
artikel
6 Cancer misinformation puts patients in harm's way Furlow, Bryant

25 2 p. 165-166
artikel
7 Classifying and grading liposarcoma by CT Sanomachi, Tomomi

25 2 p. e53
artikel
8 Correction to Lancet Oncol 2020; 21: 796–807
25 2 p. e61
artikel
9 Correction to Lancet Oncol 2023; 24: 1018–28
25 2 p. e61
artikel
10 Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis Abu Awwad, Dania

25 2 p. 225-234
artikel
11 Cutaneous blisters mimicking bullous pemphigoid Yu, Yue-Qian

25 2 p. e91
artikel
12 Developing therapies for triple-negative breast cancer subtypes Okines, Alicia

25 2 p. 149-151
artikel
13 Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial Armenian, Saro H

25 2 p. 235-245
artikel
14 Expression of concern—Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study The Editors of The Lancet Oncology,

25 2 p. e42
artikel
15 High health expenses in the WHO Western Pacific region Das, Manjulika

25 2 p. 162
artikel
16 Immunotherapy: balancing the risks and benefits The Lancet Oncology,

25 2 p. 147
artikel
17 International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations Meattini, Icro

25 2 p. e73-e83
artikel
18 Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial Bajpai, Jyoti

25 2 p. 246-254
artikel
19 Modelling radiotherapy availability in the Asia-Pacific region Lievens, Yolande

25 2 p. 152-154
artikel
20 Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis Frei, Anja L

25 2 p. 198-211
artikel
21 Multiplex immunofluorescence for tumour immune biomarker discovery Väyrynen, Juha P

25 2 p. 151-152
artikel
22 Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study Shitara, Kohei

25 2 p. 212-224
artikel
23 Nigerian competition watchdog fines British American Tobacco Burki, Talha

25 2 p. 164
artikel
24 Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial Fan, Lei

25 2 p. 184-197
artikel
25 Pembrolizumab plus chemotherapy for advanced gastric cancer Huang, Chen-yu

25 2 p. e50
artikel
26 Pembrolizumab plus chemotherapy for advanced gastric cancer Schutte, Tim

25 2 p. e51
artikel
27 Pembrolizumab plus chemotherapy for advanced gastric cancer – Authors' reply Rha, Sun Young

25 2 p. e52
artikel
28 Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study Pfister, Christian

25 2 p. 255-264
artikel
29 Primary ovarian insufficiency prediction in adult survivors of childhood cancer: model concerns Wallace, William Hamish B

25 2 p. e57
artikel
30 Primary ovarian insufficiency prediction in adult survivors of childhood cancer: model concerns Zheng, Fangjieyi

25 2 p. e58
artikel
31 Primary ovarian insufficiency prediction in adult survivors of childhood cancer: model concerns – Authors' reply Im, Cindy

25 2 p. e59-e60
artikel
32 Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study McLeod, Megan

25 2 p. e63-e72
artikel
33 Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors Leerink, Jan M

25 2 p. 154-156
artikel
34 Sub-Saharan Africa's harmonised cancer guidelines Makoni, Munyaradzi

25 2 p. 163
artikel
35 Targeted alpha therapy: a new tool for advanced prostate cancer Kairemo, Kalevi

25 2 p. 148-149
artikel
36 Thank you to The Lancet Oncology's reviewers in 2023 The Lancet Oncology Editors,

25 2 p. e43-e49
artikel
37 The GLOW trial in chronic lymphocytic leukaemia Fey, Martin

25 2 p. e54
artikel
38 The GLOW trial in chronic lymphocytic leukaemia van Gelder, Michel

25 2 p. e55
artikel
39 The GLOW trial in chronic lymphocytic leukaemia – Authors' reply Niemann, Carsten U

25 2 p. e56
artikel
40 Treatment of metastatic pancreatic cancer: 25 years of innovation with little progress for patients Gyawali, Bishal

25 2 p. 167-170
artikel
41 US radiation oncology organisations work towards Medicare payment reform Das, Manjulika

25 2 p. e62
artikel
42 World Oncology Forum amplifies its appeal in global fight against cancer Cavalli, Franco

25 2 p. 170-174
artikel
                             42 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland